Methylenedioxypyrovalerone (MDPV) impairs working memory and alters patterns of dopamine signaling in mesocorticolimbic substrates

Aarde, 2013, The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats, Neuropharmacology, 71, 130, 10.1016/j.neuropharm.2013.04.003 Adell, 2004, The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems, Neurosci. Biobehav. Rev., 28, 415, 10.1016/j.neubiorev.2004.05.001 Angoa-Perez, 2017, Neurotoxicology of Synthetic Cathinone Analogs, Curr Top Behav Neurosci, 32, 209, 10.1007/7854_2016_21 Atehortua-Martinez, 2019, Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat, J Psychopharmacol, 33, 392, 10.1177/0269881118822151 Baumann, 2013, Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive’ bath salts’ products, Neuropsychopharmacology, 38, 552, 10.1038/npp.2012.204 Beier, 2015, Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping, Cell, 162, 622, 10.1016/j.cell.2015.07.015 Carlezon, 2009, Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis, Neuropharmacology, 56, 122, 10.1016/j.neuropharm.2008.06.075 Christakis, 2012, Overstimulation of newborn mice leads to behavioral differences and deficits in cognitive performance, Sci. Rep., 2, 546, 10.1038/srep00546 Colon-Perez, 2016, The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity, Neuropsychopharmacology, 41, 2352, 10.1038/npp.2016.40 den Hollander, 2013, Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone, Pharmacol Biochem Behav, 103, 501, 10.1016/j.pbb.2012.10.006 Duart-Castells, 2019, Neuroadaptive changes and behavioral effects after a sensitization regime of MDPV, Neuropharmacology, 144, 271, 10.1016/j.neuropharm.2018.10.005 Fortin, 2018, Challenges to body fluid homeostasis differentially recruit phasic dopamine signaling in a taste-selective manner, J. Neurosci., 38, 6841, 10.1523/JNEUROSCI.0399-18.2018 Froberg, 2015, Acute methylenedioxypyrovalerone toxicity, J. Med. Toxicol., 11, 185, 10.1007/s13181-014-0446-8 Gannon, 2018, The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter, Neuropsychopharmacology, 43, 2399, 10.1038/s41386-018-0209-3 Gannon, 2017, Individual differences in the relative reinforcing effects of 3,4-Methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats, J. Pharmacol. Exp. Ther., 361, 181, 10.1124/jpet.116.239376 Gassmann, 2012, Regulation of neuronal GABA(B) receptor functions by subunit composition, Nat. Rev. Neurosci., 13, 380, 10.1038/nrn3249 Glennon, 2016, Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP), Brain Res. Bull., 126, 111, 10.1016/j.brainresbull.2016.04.011 Gregg, 2016, Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator, Neuropharmacology, 108, 111, 10.1016/j.neuropharm.2016.04.014 Hicks, 2017, Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG), Psychopharmacology (Berl.), 234, 1671, 10.1007/s00213-017-4568-y Hicks, 2018, Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats, ACS Chem. Neurosci., 9, 1327, 10.1021/acschemneuro.7b00510 Horiguchi, 2011, Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats, Psychopharmacology (Berl.), 217, 13, 10.1007/s00213-011-2251-2 Hotte, 2006, D1 receptor modulation of memory retrieval performance is associated with changes in pCREB and pDARPP-32 in rat prefrontal cortex, Behav Brain Res, 171, 127, 10.1016/j.bbr.2006.03.026 Jacobson, 2007, Specific roles of GABA(B(1)) receptor isoforms in cognition, Behav. Brain Res., 181, 158, 10.1016/j.bbr.2007.03.033 Kalivas, 1993, Neurotransmitter regulation of dopamine neurons in the ventral tegmental area, Brain Res. Brain Res. Rev., 18, 75, 10.1016/0165-0173(93)90008-N Karch, 2015, Cathinone neurotoxicity ("The "3Ms"), Curr. Neuropharmacol., 13, 21, 10.2174/1570159X13666141210225009 Kim, 2012, Coordinated activity of ventral tegmental neurons adapts to appetitive and aversive learning, PLoS One, 7 King, 2015, An assessment of MDPV-induced place preference in adult Sprague-Dawley rats, Drug Alcohol Depend., 146, 116, 10.1016/j.drugalcdep.2014.11.002 Lopez-Arnau, 2015, Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone, Toxicology and Applied Pharmacology, 286, 27, 10.1016/j.taap.2015.03.015 Marinetti, 2013, Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results, J. Anal. Toxicol., 37, 135, 10.1093/jat/bks136 Marszalek-Grabska, 2018, Effects of the positive allosteric modulator of metabotropic glutamate receptor 5, VU-29, on impairment of novel object recognition induced by acute ethanol and ethanol withdrawal in rats, Neurotox. Res., 33, 607, 10.1007/s12640-017-9857-z Motbey, 2012, Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion, PLoS One, 7, 10.1371/journal.pone.0045473 Nagai, 2007, Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex, Learn Mem, 14, 117, 10.1101/lm.461407 Nirenberg, 1997, Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area, J. Neurosci., 17, 5255, 10.1523/JNEUROSCI.17-14-05255.1997 Pignatelli, 2015, Role of dopamine neurons in reward and aversion: a synaptic plasticity perspective, Neuron, 86, 1145, 10.1016/j.neuron.2015.04.015 Prosser, 2012, The toxicology of bath salts: a review of synthetic cathinones, J. Med. Toxicol., 8, 33, 10.1007/s13181-011-0193-z Rom, 2015, miR-98 and let-7g* protect the blood-brain barrier under neuroinflammatory conditions, J. Cereb. Blood Flow Metab., 35, 1957, 10.1038/jcbfm.2015.154 Rossato, 2013, Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus, Neurobiol Learn Mem, 106, 66, 10.1016/j.nlm.2013.07.012 Segarra, 2013, The brain-heart connection: frontal cortex and left ventricle angiotensinase activities in control and captopril-treated hypertensive rats-a bilateral study, Int. J. Hypertens., 2013, 10.1155/2013/156179 Sewalia, 2018, Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV), Neuropharmacology, 134, 36, 10.1016/j.neuropharm.2017.11.034 Shanks, 2012, Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry, J. Anal. Toxicol., 36, 360, 10.1093/jat/bks047 Shekar, 2017, Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter, J. Chem. Neuroanat., 83–84, 69, 10.1016/j.jchemneu.2017.01.004 Shortall, 2013, Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat, Eur Neuropsychopharmacol, 23, 1085, 10.1016/j.euroneuro.2012.09.005 Simmler, 2013, Pharmacological characterization of designer cathinones in vitro, Br. J. Pharmacol., 168, 458, 10.1111/j.1476-5381.2012.02145.x Simmons, 2018, Comparing rewarding and reinforcing properties between’ bath salt’ 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats, Addict. Biol., 23, 102, 10.1111/adb.12479 Snigdha, 2011, Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism, Psychopharmacology (Berl.), 214, 843, 10.1007/s00213-010-2091-5 Spiller, 2011, Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States, Clin. Toxicol. Phila., 49, 499, 10.3109/15563650.2011.590812 St Onge, 2012, Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making, J. Neurosci., 32, 16880, 10.1523/JNEUROSCI.3807-12.2012 Stefani, 2006, Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum, J. Neurosci., 26, 8810, 10.1523/JNEUROSCI.1656-06.2006 Tang, 2004, Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats, J. Neurochem., 89, 1021, 10.1111/j.1471-4159.2004.02392.x Valente, 2017, Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of beta-keto amphetamines-related neurotoxicity, Arch. Toxicol., 91, 3663, 10.1007/s00204-017-1984-z Valsalan, 2017, Multi-organ dysfunction due to bath salts: are we aware of this entity?, Intern. Med. J., 47, 109, 10.1111/imj.13307 Watson, 2012, Blockade of dopamine D(3) but not D(2) receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment, Int. J. Neuropsychopharmacol., 15, 471, 10.1017/S1461145711000435 Watterson, 2014, Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV), Addict. Biol., 19, 165, 10.1111/j.1369-1600.2012.00474.x Wong, 2019, Biomed. Pharmacother., 110, 168, 10.1016/j.biopha.2018.11.044 Zbrozyna, 1991, Stimulation in prefrontal cortex inhibits conditioned increase in blood pressure and avoidance bar pressing in rats, Physiol. Behav., 49, 705, 10.1016/0031-9384(91)90306-9